Paper Details

  1. Home
  2. Paper Details

Randomized Trial Comparing the Effects of Ticagrelor Versus Clopidogrel on Myocardial Perfusion in Patients With Coronary Artery Disease.

Author: AscahKathryn J, BeanlandsRob S B, ChowBenjamin J W, DwivediGirish, HunterChad R R N, Pelletier-GalarneauMatthieu, RuddyTerrence D, deKempRobert A

Clinical Trial, Phase IIA Phase II trial is a trial that further evaluates the efficacy and safety of a new drug or treatment, whose safety has been confirmed to some extent in a Phase I trial, in a small number of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

This study investigated myocardial blood flow (MBF) in patients with stable coronary artery disease treated with ticagrelor versus clopidogrel. The findings suggest that ticagrelor may potentiate adenosine-induced MBF increases, potentially contributing to its observed reduction in mortality compared with clopidogrel.
Paper Details　
Original Abstract of the Article :
Label="BACKGROUND" NlmCategory="BACKGROUND">Ticagrelor is a P2Y<sub>12</sub> receptor inhibitor used in acute coronary syndromes to reduce platelet activity and to decrease thrombus formation. Ticagrelor is associated with a reduction in mortality incremental to that observed with clopidogrel, poten...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524115/

データ提供：米国国立医学図書館（NLM）

Ticagrelor vs. Clopidogrel: Comparing Effects on Myocardial Perfusion

This study, conducted in the field of cardiology, investigates the effects of ticagrelor and clopidogrel on myocardial perfusion in patients with coronary artery disease (CAD). It's like studying the flow of water in a desert oasis, where the health of the ecosystem depends on the quality and quantity of water supply. The researchers conducted a study to compare the effects of ticagrelor and clopidogrel on myocardial blood flow (MBF) at rest and during adenosine-induced hyperemia in patients with stable CAD.

Ticagrelor: A Promising Oasis for Myocardial Perfusion

The study's findings suggest that ticagrelor may improve myocardial perfusion compared to clopidogrel. It's like discovering a new source of water in a desert, potentially improving the health of the surrounding ecosystem. The researchers observed that ticagrelor significantly enhanced MBF during adenosine-induced hyperemia, indicating a potential benefit for patients with CAD.

Navigating the Desert of Coronary Artery Disease

This study provides valuable insights into the management of CAD, a condition that can significantly impact cardiovascular health. It's like finding a new path through a desert, offering a potentially more effective approach to treatment. The researchers emphasize the importance of carefully evaluating the benefits and risks of different antiplatelet therapies for patients with CAD.

Dr. Camel's Conclusion

This study suggests that ticagrelor may offer a more favorable impact on myocardial perfusion compared to clopidogrel, potentially improving outcomes for patients with CAD. Further research is needed to understand the long-term effects of ticagrelor and its overall impact on cardiovascular health.

Date :
  1. Date Completed 2018-03-05
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

28465300

DOI: Digital Object Identifier

PMC5524115

Related Literature

Article Analysis
・Effects of ticagrelor
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.